Abstract
In press
Background. Cervical cancer remains a leading cause of mortality among women of reproductive age in Ukraine. The effectiveness of its prevention depends on the availability and qualifications of gynecologic oncologists. A comprehensive analysis of the staffing of Ukraine's gynecologic oncology service had not been previously conducted.
Aim. To analyze regional disparities and the qualification structure of oncogynecologists in Ukraine for the periods 2015–2020 and 2022–2024, as well as to develop composite statistical indicators for identifying staffing imbalances and forecasting human resources for the cervical cancer prevention system.
Materials and Methods. A retrospective study was conducted based on official aggregated data from the Ministry of Health and the State Statistics Service for 2015–2020 and 2022–2024. For each region, the following indicators were calculated: staffing ratio (Kz), Qualification Index (QI), Proportion of Highest-category specialists (PH), Integral Staffing index (ISintegr), and Personnel Shift Rate (PSR). Statistical analysis included descriptive statistics, correlation, and factor analysis using Excel, SPSS, and RStudio packages.
Research Ethics. The study was based solely on aggregated open statistical data containing no personal information. In accordance with the standards of the WMA Declaration of Helsinki, additional ethical approval was not required.
Results. The average annual number of gynecologic oncologists was 264. A high level of regional disparity was revealed: the coefficient of variation for Kz was 43.6%. The average QI was 0.93, which is below the normative level (≥1.20). Analysis of ISintegr showed that over a third of regions have critically low staffing potential (e.g., Luhansk and Zakarpattia regions). In some regions, staff turnover exceeded 15%. A statistically significant positive correlation was found between ISintegr and the rate of early cervical cancer detection (r=0.68; p<0.01). Regions were classified into three types: potentially stable, vulnerable, and destabilized.
Conclusions. Ukraine's gynecologic oncology service is characterized by insufficient staffing and significant regional disparities. More than one-third of regions have a critically low level of human resource potential. The established direct link between the integral staffing index and the effectiveness of early diagnosis underscores the key role of staff quality and stability. The proposed composite indicators, particularly ISintegr, can serve as an effective tool for evidence-based management planning for cervical cancer prevention for 2025–2030.
Keywords: oncogynecology, health care management, regional disproportions, cervical cancer, integral index of availability, medical statistics.
References
Sahasrabuddhe VV. Cervical Cancer: Precursors and Prevention. Hematol Oncol Clin North Am. 2024;38(4):771-81. DOI: 10.1016/j.hoc.2024.03.005. PMID: 38760198.
Voelker RA. Cervical Cancer Screening. JAMA. 2023;330(20):2030. DOI: 10.1001/jama.2023.21987. PMID: 37889510.
Jha AK, Mithun S, Sherkhane UB, Jaiswar V, Osong B, Purandare N, Kannan S, et al. Systematic review and meta-analysis of prediction models used in cervical cancer. Artif Intell Med. 2023;139:102549. DOI: 10.1016/j.artmed.2023.102549. PMID: 37100501.
Sefuthi T, Nkonki L. A systematic review of economic evaluations of cervical cancer screening methods. Syst Rev. 2022;11(1):162. DOI: 10.1186/s13643-022-02017-z. PMID: 35945642.
Robinson EF, Darby JP, Moulder JK. Cervical cancer screening: missed opportunities in a one-track model. Int J Gynecol Cancer. 2023;33(4):646. DOI: 10.1136/ijgc-2023-004311. PMID: 36750270.
Kojalo U, Tisler A, Parna K, Kivite-Urtane A, Zodzika J, Stankunas M, et al. An overview of cervical cancer epidemiology and prevention in the Baltic States. BMC Public Health. 2023;23(1):660. DOI: 10.1186/s12889-023-15524-y. PMID: 37029357.
Wang J, Elfström KM, Dillner J. Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden. Lancet Public Health. 2024;9(11):e886-95. DOI: 10.1016/S2468-2667(24)00218-4. PMID: 39486904.
Rahangdale L, Teodoro N, Chinula L, Brewer NT. Eliminating cervical cancer as a global public health problem requires equitable action. BMJ. 2023;383:2978. DOI: 10.1136/bmj.p2978. PMID: 38135345.
Wilailak S, Kengsakul M, Kehoe S. Worldwide initiatives to eliminate cervical cancer. Int J Gynaecol Obstet. 2021;155 Suppl 1(Suppl 1):102-6. DOI: 10.1002/ijgo.13879. PMID: 34669201.
Li DJ, Shi J, Jin J, Du NY, He YT. [Epidemiological trend of cervical cancer]. Zhonghua Zhong Liu Za Zhi. 2021;43(9):912-916. DOI: 10.3760/cma.j.cn112152-20190904-00573. PMID: 34530572. [In Chinese].
Duru G, Topatan S. A barrier to participation in cervical cancer screenings: fatalism. Women Health. 2023;63(6):436-44. DOI: 10.1080/03630242.2023.2223698. PMID: 37303197.
Gnade CM, Hill EK, Botkin HE, Hefel AR, Hansen HE, Sheets KA, et al. Is the age of cervical cancer diagnosis changing over time? J Gynecol Obstet Hum Reprod. 2021;50(7):102040. DOI: 10.1016/j.jogoh.2020.102040. PMID: 33316464.
Kulasingam SL, de Kok IMCM, Mehta A, Jansen EEL, Regan MC, Killen JW, et al. Estimated Cancer Risk in Females Who Meet the Criteria to Exit Cervical Cancer Screening. JAMA Netw Open. 2025;8(3):e250479. DOI: 10.1001/jamanetworkopen.2025.0479. PMID: 40072436.
Degife EA, Oliveira CR, Znamierowski E, Meyer JP, Sheth SS. Uptake of Cervical Cancer Screening Among Female Patients Using a Mobile Medical Clinic. Am J Prev Med. 2023;65(5):835-43. DOI: 10.1016/j.amepre.2023.05.013. PMID: 37220860.
Brüggmann D, Quinkert-Schmolke K, Jaque JM, Quarcoo D, Bohlmann MK, Klingelhöfer D, Groneberg DA. Global cervical cancer research: A scientometric density equalizing mapping and socioeconomic analysis. PLoS One. 2022;17(1):e0261503. DOI: 10.1371/journal.pone.0261503. PMID: 34990465.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
